Genetic association of the KLK4 locus with risk of prostate cancer.
The Kallikrein-related peptidase, KLK4, has been shown to be significantly overexpressed in prostate tumours in numerous studies and is suggested to be a potential biomarker for prostate cancer. KLK4 may also play a role in prostate cancer progression through its involvement in epithelial-mesenchyma...
Guardado en:
Autores principales: | Felicity Lose, Srilakshmi Srinivasan, Tracy O'Mara, Louise Marquart, Suzanne Chambers, Robert A Gardiner, Joanne F Aitken, Australian Prostate Cancer BioResource, Amanda B Spurdle, Jyotsna Batra, Judith A Clements |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01315c51f5e34bb6845a35b919654b57 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.
por: Jyotsna Batra, et al.
Publicado: (2011) -
A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness
por: John Lai, et al.
Publicado: (2017) -
KLK3 SNP–SNP interactions for prediction of prostate cancer aggressiveness
por: Hui-Yi Lin, et al.
Publicado: (2021) -
Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency
por: Lakmali Munasinghage Silva, et al.
Publicado: (2017) -
A KLK4 proteinase substrate capture approach to antagonize PAR1
por: Eitan Rabinovitch, et al.
Publicado: (2021)